Helen Collins

2018

In 2018, Helen Collins earned a total compensation of $1.3M as Senior Vice President and Chief Medical Officer at Five Prime Therapeutics, a 51% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$168,960
Option Awards$596,380
Salary$435,000
Stock Awards$130,830
Other$6,036
Total$1,337,206

Collins received $596.4K in option awards, accounting for 45% of the total pay in 2018.

Collins also received $169K in non-equity incentive plan, $435K in salary, $130.8K in stock awards and $6K in other compensation.

Rankings

In 2018, Helen Collins' compensation ranked 7,731st out of 14,244 executives tracked by ExecPay. In other words, Collins earned more than 45.7% of executives.

ClassificationRankingPercentile
All
7,731
out of 14,244
46th
Division
Manufacturing
3,011
out of 5,765
48th
Major group
Chemicals And Allied Products
1,127
out of 2,128
47th
Industry group
Drugs
951
out of 1,817
48th
Industry
Pharmaceutical Preparations
741
out of 1,391
47th

Pay ratio

Helen Collins' Pay$1,337,206
Median Employee's Pay$201,670
Pay Ratio

7

to 1

In 2018, the annual total compensation of Helen Collins was $1,337,206.

The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.

The ratio of Helen Collins' pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 29, 2019.

Collins' colleagues

We found six more compensation records of executives who worked with Helen Collins at Five Prime Therapeutics in 2018.

2018

Aron Knickerbocker

Five Prime Therapeutics

Chief Executive Officer

2018

David Smith

Five Prime Therapeutics

Chief Financial Officer

2018

Bryan Irving

Five Prime Therapeutics

Chief Scientific Officer

2018

Francis Sarena

Five Prime Therapeutics

Secretary

2018

Linda Rubinstein

Five Prime Therapeutics

Chief Financial Officer

2018

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

News

You may also like